Degradation or alteration of FN1 expression has been associated with cancer progression, such as in squamous cell carcinoma, nasopharyngeal carcinoma, ovarian cancer, and renal cancer (Sung et al., 2011; Xiao et al., 2018; Takayasu et al., 2001). This evidence concerns the gene FN1 and ovarian carcinoma.